The affected tube sizes including 2.0, 2.5, 3.0 and 3.5 mm, pose a serious risk of inadequate ventilation, which could lead to hypoxia, overdose, cardiopulmonary collapse or death, according to a March 10 news release from the FDA.
Affected customers and distributors have been notified and provided instructions for identifying the affected products. The company has received eight reports of serious injuries linked to this issue.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
